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We have been treating endoscopically different kinds of inverted papilloma including malignant inverted 
papilloma since 1995. This is a retrospective study which demonstrates our experience in the treatment of 
inverted papilloma. Inverted papilloma is defined as a benign, locally aggressive tumor with malignant 
transformation and frequent recurrence. The aim of the study is to investigate whether the malignancy starts 
developing at the beginning of disease or later, and whether we can consider deviated septum as a etiologic 
factor of inverted papilloma. We also wanted to show endoscopic endonasal surgery as a method of choice in 
the treatment of inverted papilloma. Data in the period from 1998 to 2017 were analyzed retrospectively. Out 
of a total number of 62 patients, three (4.8%) were diagnosed with inverted papilloma with squamous cell 
carcinoma in some part of the lesion and 59 (95.2%) were diagnosed like inverted papilloma. The patients 
diagnosed with inverted papilloma and with squamous cell carcinoma were significantly older than the 
patients diagnosed with IP (Mann-Whitney U test, p = 0.006). The most common localization of primary 
tumor was the maxillary sinus. The dominant symptom in patients with inverted papilloma was epistaxis in 
more than half of our patients, followed by nasal obstruction in more than one third of our patients. We 
compared our results with the results from literature. Our results show a low percentage of malignant 
transformation only in three cases (4.8%). The obtained result corresponds to previous studies, with values 
below the average obtained in other studies. Finally, the endoscopic endonasal approach is the contemporary 
gold standard in the treatment of inverted papilloma. 




Od 1995. godine endoskopskim pristupom liječimo različite oblike invertnog papiloma, uključujući i 
zloćudni invertni papilom. Ovom retrospektivnom studijom pokazali smo naša iskustva u liječenju invertne 
bolesti. Invertni papilom definira se kao benigni, lokalno agresivni tumor sklon malignoj transformaciji i 
čestim recidivima. Cilj studije bio je istražiti razvija li  se zloćudni tumor odmah na početku, ili do maligne 
transformacije dolazi kasnije, te ima li devijacija septuma utjecaj na razvoj invertnog papiloma. Također smo 
željeli prikazati endoskopski endonazalni pristup kao metodu izbora u liječenju invertnog papiloma. Podaci u 
razdoblju od 1998. do 2017. godine analizirani su retrospektivno. Od ukupnoga broja bolesnika 62, kod njih 
troje (4,8%), postavljena je dijagnoza invertnog papiloma s karcinomom pločastih stanica u dijelu invertnog 
papiloma, a dok je kod njih 59 (95,2%) postavljena dijagnoza invertnog papiloma. Bolesnici s dijagnozom 
invertnog papiloma s karcinomom pločastih stanica bili su značajno stariji od bolesnika s dijagnozom 
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invertnog papiloma (Mann-Whitney U test, p = 0,006). Maksilarni sinus najčešće je sijelo primarnoga tumora. 
Epistaksa predstavlja dominantni simptom invertnog papiloma u više od polovine bolesnika, a slijedi ju nosna 
opstrukcija, zapažena kod više od trećine bolesnika. Usporedili smo naše rezultate s rezultatima iz literature. 
Naši rezultati pokazuju nizak postotak maligne transformacije u samo  tri bolesnika, odnosno u  4,8% 
slučajeva. Dobiveni rezultat odgovara ranijim istraživanjima, s time što dobivene vrijednosti spadaju u niže 
od prosjeka dobivenih u drugim istraživanjima. U našem istraživanju potvrdili smo kako je endoskopski 
endonazalni pristup metoda izbora u liječenju invertnog papiloma. 








Inverted papillomas (IP) are benign sinonasal 
tumors that originate from the Schneiderian membrane 
formed from layers of squamous type cells, transitional 
and ciliated columnar epithelium.1 It covers about 0.5-
4% of all primary tumors in the nose and paranasal 
sinuses and is one of the most common benign lesions 
of the described anatomical region with male-to- 
female ratio 3.4:1 and the peak onsets in the 4th-7th 
decade of life.2,3 
There are three main characteristic features. One of 
the most important characteristics of the IP is the ability 
to spread to surrounding tissues and the destruction of 
the osseous areas of the nasal cavity and sinuses, 
spreading over the facial skeleton and the anterior 
cranial fossa, a high propensity for recurrence and         
the possibility of malignant alteration.4 Chronic 
inflammation, nicotinism, allergy or occupational 
exposures are some of the factors having the role in 
respiratory mucosa remodeling into IP. Some studies 
described the possibility of HPV as a possible factor in 
the development of IP. The percentage of positive 
HPV among IP ranged between 38 and 63%, but 
further research is needed.5,6 
Recent study7 confirmed the incidence of malignancy 
in their work 5.1% with other literature, which 
suggests that the incidence of malignancy among 
patients with IP varies widely and ranges from 2-27%.8,9 
Most histological interpretations confirmed squamous 
cell carcinoma (SCC) although mucoepidermoid 
carcinomas, small cell carcinomas, adenocarcinomas 
were associated with IP.10 The association of inverted 
papilloma with the development of SCC according to 
available data in literature is between 10 and 20%.8 
With respect to the ability of local destruction, the 
tendency of recurrence and malignant transformation, 
a large number of surgeons recommend an open 
surgical approach as the therapy of choice in advanced 
cases.11 In order to facilitate the recovery of patients 
after surgery and a better quality of life, more surgeons 
are deciding for the endoscopic approach because 
endoscopic techniques have shown excision control 
rates comparable to the traditional open methods - 
external frontoethmoidectomy and lateral rhinotomy.12 
The aim of the study was to retrospectively analyze 
62 patients and their treatment experiences. During the 
research, it was observed that there was a deviation of 
septum on the same side where IP and / or IP with SCC 
occurred. We also wanted to investigate if the patient's 
age is a predictive factor in the development of IP with 
SCC. Lastly to show Endoscopic Endonasal Surgery as 
a method of choice in the treatment of IP. 
 
Patients and methods 
 
This retrospective study involved 62 participants 
who were diagnosed IP or carcinoma associated with 
IP in the nasal cavity and paranasal sinuses in the 
Otorhinolaryngology and Head and Neck Surgery 
Clinic in Osijek during 20 years from the begining of 
the research 1998. The study included 45 males and 17 
females. The median age of all patients was 59 years 
(interquartile range of 50.25 to 68 years). In three cases 
we noticed a malignant transformation; in two males 
and one female. The follow up period was 15 years. 
The criteria for inclusion in the study were age 18 or 
older, and subjects with histologically confirmed 
diagnosis of IP or carcinoma associated with IP in the 
nasal cavity and paranasal sinuses. The criteria for 
exclusion from the study was the absence at follow-up 
treatments. A detailed history of the disease and an 
endoscopic examination were taken from all the 
patients. Prior to the endoscopic endonasal surgery 
which was performed by two surgeons, all the patients 
had a CT scan performed. Endoscopic endonasal 
surgery was performed in the general endotracheal 
anesthesia. All participants were introduced to the 
study purpose and protocol and signed informed 
consent approval to the examination procedure. The 
study protocol was approved by the Ethical Committee 
of Osijek University Hospital Centre and the Ethics 
Committee of the Faculty of Medicine in Osijek, and it 
was conducted with the Nuremberg Code and the latest 
revision of the Helsinki Declaration. 
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Categorical data were represented by absolute and 
relative frequencies. Numerical data were described by 
the median and the limits of the interquartile range 
(IQR). The differences of categorical variables were 
tested by Fisher's Exact. All P values are two - sided. 
A p-value of less than 0.05 was considered statistically 
significant. The statistical analysis was performed 
using the MedCalc Statistical Software version 19.4.1 
(MedCalc Software Ltd, Ostend, Belgium; https:// 
www.medcalc.org; 2020), and SPSS 17.0 (SPSS Inc., 




In the last 20 years, we have treated 62 patient with 
inverted papilloma. Each patient was preoperatively 
examined – necessary CT scan and underwent endo-
scopic endonasal surgery performed by two surgeons. 
The follow-up period for each patient was 15 years. 
Data in the period from 1998 to 2017 were analyzed 
retrospectively. Out of the total number of patients, 59 
(95.2%) were diagnosed with IP and 3 (4.8%) in a 
certain part of the IP, and the diagnosis of SCC was 
confirmed.  
Patients diagnosed IP with SCC were significantly 
older than patients diagnosed with only IP (Mann-
Whitney U test, p = 0.006). There is no significant 
difference in the diagnosis of IP with SCC and IP with 
respect to gender (Fisher´s exact test, p > 0.99) (Table 1.). 
The maxillary sinus was confirmed by both 
imaging radiological methods and operative findings 
as the most common primary site in 45.76% in patient 
with IP and 66.67% in patients with IP with SCC. In 
the second place, the most common primary site of IP 
was ethmoid, while frontal recess, sphenoid, nasal 
septum and inferior turbinate were present in only one 
case of IP out of the total number of patients. Table 2 
demonstrates the origin site of the primary lesion. 
Patients complained of epistaxis as the first 
symptom that would indicate the development of IP 
and IP with SCC. Nasal obstruction was the second 
most common cause observed during the disease 
development. Other symptoms included cheek pain. 
The least common are epiphora and decreased vision 
(Table 3).
 
Table 1 Diagnosis according to gender 
Tablica 1. Dijagnoza prema spolu 
 
 Participants (%) according to gender  









IP with SCC 2 (4) 1 (6) 3 (5) 
> 0.05 IP 43 (96) 16 (94) 59 (95) 
Total/Sveukupno 45 (100) 17(100) 62 (100) 
* Fisher´s exact test, p > 0.99, Fisherov točni test p > 0,99 
 
 
Table 2 Localization of primary tumor 








Maxillary 27 (45,76%) 2 
(66,67
%) 
Ethmoid 18 (30,51%)  
Lateral nasal 
wall 
6 (10,17%)  
Papiracea 4 (6,78%)  
Frontal recess 1 (1,69%) 1 
(33,33
%) 
Sphenoid 1 (1,69%)  
Nasal septum 1 (1,69%)  
Inferior 
Turbinate 
1 (1,69%)  
Table 3 Dominant symptom in patients with IP and SCC  








Epistaxis 32 (54,24%) 2 (96.55%) 
Nasal obstruction 22 (37,23%) 1 (3.45%) 
Cheek pain/Bolovi 
obraza 
3 (5,08%)  
Epiphora 1 (1,69%)  
Decreased 
vision/Smanjeni vid 
1 (1,69%)  
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Table 4. The presence of deviated septum with respect to diagnosis IP and IP with SCC 
Tablica 4. Prisutnost devijacije septuma u odnosu na dijagnozu IP te IP s SCC 
 
 Number (%) of patients according 
to diagnosis 





IP IP with SCC 
Deviated septum 
Devijacija septuma 
Yes/Da 53 (90) 2 (67) 55 (89)  
< 0.05 No/Ne 6 (10) 1 (33) 7 (11) 
Total 59 (100) 3 (100) 62 (100) 
* Fisher´s exact test, p < 0.30, Fisherov točni test p > 0,30 
 
Of the total number of 62 patients, 55 (88.7%) had 
a deviated septum on the same side where IP and IP 
with SCC were localized. A comparison of patients 
with IP and IP with SCC showed that there was a 
significantly higher number of patients with septal 
deformity in the group of patients with IP and SCC. 
This data cannot be interpreted due to the small number 
of patients with IPP and SCC included in this study. 
(Table 4). 
The open method external frontoethmoidectomy 
was required only in one patient for there was an 
extension of the IP to the frontal sinus area and bone 
destruction. We did not notice a discrepancy between 
the CT findings and the intraoperative bone destruction 
findings in the last 13 years of study. During a twenty-
year study period in three patients, reoperation was 
required due to the recurrence of IP by endoscopic 
approach because there was no need for an open 
technique. During the follow-up period, there was no 
occurrence of SCC after IP removal. We have no data 




Picture 1 Squamous cell carcinoma in 74-year-old 
woman 




Picture 2 Nasal septum deviation on the same side of 
the localization of inverted papilloma 
Slika 2.  Devijacija nazalnog septum na istoj strani 




We have been treating patients with endoscopically 
different kinds of inverted papilloma, including and 
malignant inverted papilloma since 1995. This is a 
retrospective study which demonstrates our experience 
in the treatment of inverted papilloma. 
Only a few studies have recorded the characteristics 
and survival rates of IP-related carcinomas.13 SCC is 
considered to be the most common malignant tumor 
arising from IP.14 SCC in IP occurs synchronously, 
localized in the same initial place or synchronously, 
arising on the same site where the IP had already been 
operated.15 Symptoms like epistaxis, rhinorrhea, nasal 
obstruction, and anosmia are directly associated        
with IP and/or SCC-related IP incidence. However, 
unfortunately, these symptoms are not specific to allow 
the diagnosis of IP or SCC-related IP. During an 
investigation, we have noticed that the most common 
localization of primary tumor was the maxillary sinus. 
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The dominant symptom in patients with inverted 
papilloma was epistaxis in more than half of our 
patients, followed by a nasal obstruction in more than 
one-third of our patients. In support of the poor 
prognosis of the SCC, data are showing that 5 and 10 - 
year survival reaches 39.6% and 31.8%.16 The same 
authors found that the prognosis is worse when the 
diagnosis is made in elderly age. The tumor shows low 
differentiation, an advanced stage, and infiltrates the 
cranial base or orbital cavity. Some authors reported 
MRI as a helpful diagnostic tool in recognizing IP 
malignant transformation. Inverted papilloma in the 
MRI should be indicated by a convoluted cerebriform 
pattern, a bandlike region of hyperintense and 
hypointense signals on T2 weighted images17 Focal 
loss of the cerebriform pattern is an indicator for 
simultaneous IP with malignant alteration13,18 Fujima 
et al. proposed that tumor blood flow measurement 
values can be used to differentiate SCC and IP.19 
In our study, all three SCC cases associated with IP 
appeared as a primary case, not as a recurrence of IP in 
elderly patients. According to these results, older age 
could be a predictive factor in cancer development, 
primarily in contrast to recurrent IP. Reccurrence is a 
predictive factor of malignant alteration. In order to 
confirm this thesis, further research and follow-up on 
a larger sample are needed.  
We noticed in the 55 (88.7%) of a total of 62 
patients, the nasal septum deviated on the same side 
where IP and IP with SCC were localized. Such a high 
percentage of coincidence of septal deviation and IP 
ipsilaterally can be explained by the generally high 
percentage of septum deviation in the general 
population, about 80%.20,21 A comparison of patients 
with IP and IP with SCC showed a significantly higher 
number of patients with a septal deformity in the group 
of patients with IP and SCC. This data cannot be 
interpreted due to the small number of patients with IP 
and SCC included in this study. Septum deviation 
plays an essential role in nasal congestion and 
increased nasal airway resistance thickening of the 
maxillary sinus mucosa, and it is associated with 
increased prevalence of chronic inflammation.21-23 
Danese et al. demonstrated that anatomical deformity 
source of obstruction would lead to the accumulation 
and retention of secretions as predispositions for 
inflammation.25 Also, it has been noted that septum 
deviation increases the nose's airflow velocity with 
consequent mucosal dryness and impaired mucociliary 
clearance.25 So far, the association between a deviated 
septum and IP formation has not been described in the 
literature. We noticed that a deviated septum could 
cause chronic inflammation, which is one factor in the 
development of IP. From the obtained result, it is 
difficult to claim that septum deformities cause IP, but 
further research is needed. Patients with IP should be 
operated on, although it is not always entirely 
confident whether it will be an open or endoscopic 
approach.26,27 The type of approach that will be chosen 
depends primarily on the size of the tumor, its 
localization, spreading to surrounding areas, and the 
surgeon's experience. Endoscopic endonasal resection 
is the gold standard in the treatment for sinonasal IP. 
This approach is described with good outcomes for 
treating benign and selected malignant tumors with an 
intracranial extension.28 Therefore, this study's main 
limitations are the small number of patients, primarily 
IP with SCC, and insufficient data on patients who 
were not available to us like CT images to confirm the 





The endoscopic endonasal approach is a surgical 
treatment of choice with good outcomes for treating 
both other benign and selected malignant tumors. 
Elderly age plays a role in the early malignant 
transformation of IP. Continuous health professionals' 
education and early diagnosis with an early surgical 
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